Home
Conditions
Treatments
Trials
Explore
🏠
/
treatments
/
TM4SF1- and EpCAM-positive chimeric antigen receptor T-cell therapy
/
mega-study
TM4SF1- and EpCAM-positive chimeric antigen receptor T-cell therapy